{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T05:41:13Z","timestamp":1777009273478,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["fsijournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.forsciint.2014.08.014","type":"journal-article","created":{"date-parts":[[2014,8,26]],"date-time":"2014-08-26T14:34:54Z","timestamp":1409063694000},"page":"122-127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Development of application protocols of the Emit\u00ae II Plus 6-Acetylmorphine Assay on the ADVIA\u00ae 1800 and 2400 Chemistry Systems"],"prefix":"10.1016","volume":"244","author":[{"given":"Julie A.","family":"Warren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Gerald","family":"Siefring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nihmat","family":"Morjana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2014.08.014_bib0005","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2165\/00003088-198510050-00002","article-title":"Clinical significance of esterases in man","volume":"10","author":"Williams","year":"1985","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0010","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1093\/jat\/32.4.265","article-title":"Driving under the influence of opiate: concentration between morphine, codeine, 6-acetylmorphine, and ethyl morphine","volume":"32","author":"Jones","year":"2008","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0015","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2174\/157488406775268219","article-title":"Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: review of the literature","volume":"1","author":"Rook","year":"2006","journal-title":"Curr. Clin. Pharmacol."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0020","series-title":"Disposition of Toxic Drugs and Chemicals in Man","first-page":"730","author":"Baselt","year":"2008"},{"key":"10.1016\/j.forsciint.2014.08.014_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jat\/15.1.1","article-title":"Forensic drug testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug assay considerations and detection time","volume":"15","author":"Cone","year":"1991","journal-title":"J. Anal. Toxicol."},{"issue":"228","key":"10.1016\/j.forsciint.2014.08.014_bib0030","first-page":"71858","article-title":"Mandatory Guidelines for Federal Workplace Drug Testing Programs, Department of Human Services, SAMHSA","volume":"73","author":"Substance Abuse Mental Health Services Administration","year":"2008","journal-title":"Federal Register"},{"key":"10.1016\/j.forsciint.2014.08.014_bib0035","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.forsciint.2012.02.004","article-title":"Performance of the Emit II Plus 6-Acetylmorphine Assay on the Viva-E Analyzer","volume":"220","author":"Yau","year":"2012","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1093\/jat\/25.7.515","article-title":"Detection of opiate use in a methadone maintenance treatment population with the CEDIA 6-acetylmorphine and CEDIA DAU opiate assays","volume":"25","author":"Spanbauer","year":"2001","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1093\/jat\/28.6.489","article-title":"Comparison of the microgenic CEDIA heroin metabolite (6-AM) and the Roche Abuscreen ONLINE opiate immunoassays fro the detection of heroin use in forensic urine samples","volume":"28","author":"Holler","year":"2004","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jat\/29.3.201","article-title":"Evaluation of the Cedia heroin metabolite (6-AM) immunoassay with urine specimens from a criminal justice drug-testing program","volume":"28","author":"Jenkins","year":"2005","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0055","first-page":"S43","article-title":"Interference testing","volume":"29","author":"Dimeski","year":"2008","journal-title":"Clin. Biochem. Rev."},{"issue":"71","key":"10.1016\/j.forsciint.2014.08.014_bib0060","first-page":"19644","article-title":"Draft Guideline for Federal Workplace Drug Testing Programs, Department of Human Services, SAMHSA","volume":"69","author":"Substance Abuse Mental Health Services Administration","year":"2004","journal-title":"Federal Register"},{"key":"10.1016\/j.forsciint.2014.08.014_bib0065","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0003-2670(00)81721-3","article-title":"Determination of 6-acetylmorphine in urine as a specific marker for heroin abuse by high-performance liquid chromatography with fluorescence detection","volume":"170","author":"Derks","year":"1985","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.forsciint.2014.08.014_bib0070","first-page":"221","article-title":"The quantitative analysis of heroin, methadone and their metabolites and the simultaneous detection of cocaine, acetylcodeine and their metabolites in human plasma by high-performance liquid chromatography coupled with tandem mass spectrometry","volume":"824","author":"Rook","year":"2005","journal-title":"J. Chromatogr."},{"key":"10.1016\/j.forsciint.2014.08.014_bib0075","series-title":"Urine Testing for Drugs of Abuse","first-page":"30","article-title":"Analytical Methodology in methodology","volume":"vol. 73","author":"Hawks","year":"1986"}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814003284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0379073814003284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T04:59:56Z","timestamp":1538283596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0379073814003284"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":15,"alternative-id":["S0379073814003284"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.08.014","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of application protocols of the Emit\u00ae II Plus 6-Acetylmorphine Assay on the ADVIA\u00ae 1800 and 2400 Chemistry Systems","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2014.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}